Aberrant Drug-Related Behaviors: Unsystematic Documentation Does Not Identify Prescription Drug Use Disorder

Pain Medicine (United States)

Volumn 13, Issue 11, 2012, Pages 1436-1443

  Meltzer, Ellen C ^a,b   Rybin, Dennis ^c   Meshesha, Lidia Z ^a   Saitz, Richard ^a,c   Samet, Jeffrey H ^a,c   Rubens, Sonia L ^a,d   Liebschutz, Jane M ^a,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF KANSAS   (United States)

Author keywords

Aberrant Drug Related Behaviors; Chronic Pain; Diagnosis; Prescription Drug Use Disorder; Primary Care

Indexed keywords

ANALGESIC AGENT; BENZODIAZEPINE DERIVATIVE; OPIATE;

ABERRANT DRUG RELATED BEHAVIOR; ADULT; ARTICLE; BEHAVIOR DISORDER; CHRONIC PAIN; CROSS-SECTIONAL STUDY; DRUG ABUSE; DRUG ABUSE PATTERN; DSM-IV; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; OUTCOME ASSESSMENT; PRESCRIPTION; PRESCRIPTION DRUG USE DISORDER;

EID: 84869166026     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2012.01497.x     Document Type: Article

References (40)

1. Gureje O, Von Korff M, Simon GE, Gater R. Persistent pain and well-being: A World Health Organization study in primary care. [erratum appears in JAMA 1998 Oct 7;280(13):1142]. JAMA 1998;280(2):147-51.
2. Marks RM, Sachar EJ. Undertreatment of medical inpatients with narcotic analgesics. Ann Intern Med 1978;78:173-81.
3. Cicero TJ, Inciardi JA, Munoz A. Trends in abuse of oxycontin and other opioid analgesics in the United States: 2002-2004. J Pain 2005;6(10):662-72.
4. Bell J. The global diversion of pharmaceutical drugs: Opiate treatment and the diversion of pharmaceutical opiates: A clinician's perspective. Addiction 2010;105(9):1531-7.
5. Centers for Disease Control and Prevention (CDC). Emergency department visits involving nonmedical use of selected prescription drugs-United States, 2004-2008. MMWR Morb Mortal Wkly Rep 2010;59(23):705-9.
6. Reidenberg MM, Willis O. Prosecution of physicians for prescribing opioids to patients. Clin Pharmacol Ther 2007;81(6):903-6.
7. Webster LR, Cochella S, Dasgupta N, etal. An analysis of the root causes for opioid-related overdose deaths in the United States. Pain Med 2011;12(suppl 2):S26-35.
8. Smith DE. Prescribing practices and the prescription drug epidemic: Physician intervention strategies. J Psychoactive Drugs 2012;44(1):68-71.
9. Chou R, Fanciullo GJ, Fine PG, etal. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009;10(2):113-30.
10. American Psychiatric Association, Task Force on DSM-IV. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR), 4th edition. Washington, DC: American Psychiatric Association; 2000:xxxvii, 943.
11. Portenoy RK. Opioid therapy for chronic nonmalignant pain: A review of the critical issues. J Pain Symptom Manage 1996;11(4):203-17.
12. Inciardi JA, Surratt HL, Cicero TJ, etal. The "black box" of prescription drug diversion. J Addict Dis 2009;28(4):332-47.
13. Weissman DE, Haddox JD. Opioid pseudoaddiction-An iatrogenic syndrome. Pain 1989;36(3):363-6.
14. Dunbar SA, Katz NP. Chronic opioid therapy for nonmalignant pain in patients with a history of substance abuse: Report of 20 cases. J Pain Symptom Manage 1996;11(3):163-71.
15. Passik SD, Kirsh KL, McDonald MV, etal. A pilot survey of aberrant drug-taking attitudes and behaviors in samples of cancer and AIDS patients. J Pain Symptom Manage 2000;19(4):274-86.
16. Michna E, Ross EL, Hynes WL, etal. Predicting aberrant drug behavior in patients treated for chronic pain: Importance of abuse history. J Pain Symptom Manage 2004;28(3):250-8.
17. Ives TJ, Chelminski PR, Hammett-Stabler CA, etal. Predictors of opioid misuse in patients with chronic pain: A prospective cohort study. BMC Health Serv Res 2006;6:46.
18. Fleming MF, Balousek SL, Klessig CL, Mundt MP, Brown DD. Substance use disorders in a primary care sample receiving daily opioid therapy. J Pain 2007;8(7):573-82.
19. Kirsh KL, Whitcomb LA, Donaghy K, Passik SD. Abuse and addiction issues in medically ill patients with pain: Attempts at clarification of terms and empirical study. Clin J Pain 2002;18(4 suppl):S52-60.
20. Wasan AD, Butler SF, Budman SH, etal. Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients? Clin J Pain 2009;25(3):193-8.
21. Butler SF, Budman SH, Fernandez K, Jamison RN. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain 2004;112(1-2):65-75.
22. Weaver MF, Bond DS, Arnold BL, Waterhouse E, Towne A. Aberrant drug-taking behaviors and headache: Patient versus physician report. Am J Health Behav 2006;30(5):475-82.
23. Compton P, Darakjian J, Miotto K. Screening for addiction in patients with chronic pain and "problematic" substance use: Evaluation of a pilot assessment tool. J Pain Symptom Manage 1998;16(6):355-63.
24. Meltzer EC, Rybin D, Saitz R, etal. Identifying prescription opioid use disorder in primary care: Diagnostic characteristics of the current opioid misuse measure (COMM). Pain 2011;152(2):397-402.
25. Liebschutz JM, Saitz R, Weiss RD, etal. Clinical factors associated with prescription drug use disorder in urban primary care patients with chronic pain. J Pain 2010;11(11):1047-55.
26. Baxter RJ, Mechanic RE. The status of local health care safety nets. Health Aff (Millwood) 1997;16(4):7-23.
27. Kessler RC, Andrews G, Mroczek D, Ustun B, Wittchen HU. The World Health Organization Composite International Diagnostic Interview short-form (CIDI-SF). Int J Methods Psychiatr Res 1998;7(4):171-85.
28. Zacny J, Bigelow G, Compton P, etal. College on problems of drug dependence taskforce on prescription opioid non-medical use and abuse: Position statement. Drug Alcohol Depend 2003;69(3):215-32.
29. Katz NP, Adams EH, Benneyan JC, etal. Foundations of opioid risk management. Clin J Pain 2007;23(2):103-18.
30. Von Korff M, Ormel J, Keefe FJ, Dworkin SF. Grading the severity of chronic pain. Pain 1992;50(2):133-49.
31. McCarberg B, Passik SD. Expert Guide to Pain Management. Philadelphia, PA: American College of Physicians; 2005.
32. Martell BA, O'Connor PG, Kerns RD, etal. Systematic review: Opioid treatment for chronic back pain: Prevalence, efficacy, and association with addiction. Ann Intern Med 2007;146(2):116-27.
33. Ossipov MH, Lai J, King T, Vanderah TW, Porreca F. Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure. Biopolymers 2005;80(2-3):319-24.
34. Portenoy RK. Opioid therapy for chronic nonmalignant pain: Clinician's perspective. J Law Med Ethics 1996;24(4):296-309.
35. Jonsen AR, Siegler M, Winslade WJ. Clinical Ethics: A Practical Approach to Ethical Decisions in Clinical Medicine, 7th edition. New York: McGraw-Hill Medical; 2010.
36. Liebschutz JM, Alford DP. Safe opioid prescribing: A long way to go. J Gen Intern Med 2011;26(9):951-2.
37. Krebs EE, Ramsey DC, Miloshoff JM, Bair MJ. Primary care monitoring of long-term opioid therapy among veterans with chronic pain. Pain Med 2011;12(5):740-6.
38. Butler SF, Budman SH, Fernandez KC, etal. Development and validation of the current opioid misuse measure. Pain 2007;130(1-2):144-56.
39. Fletcher RH, Fletcher SW. Clinical Epidemiology the Essentials, 4th edition. Baltimore, MD: Lippincott Williams & Wilkins; 2005.
40. McCabe SE, Teter CJ, Boyd CJ. Medical use, illicit use, and diversion of abusable prescription drugs. J Am Coll Health 2006;54(5):269-78.